Terrie Curran, President and Chief Executive at Phathom Pharmaceuticals, Inc. (PHAT), bought 25,838 shares at $7.82 ($202K) on 2023-04-06, disclosed to the SEC on 2023-04-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.82 | 12,919 | $101K | 50.0% |
| 2 | $7.82 | 12,919 | $101K | 50.0% |
| Total | $7.82 avg | 25,838 | $202K | 100% |
| Filing → |
| PHAT | SELL | 2025-01-23 | $252K | — | Filing → |
| ARQT | SELL | 2024-11-13 | $189K | — | Filing → |
| PHAT | SELL | 2024-07-17 | $793K | — | Filing → |